Why do Healthcare Professionals Increase the Adoption of Calprotectin Testing? The healthcare sector is rapidly growing due to its innovations and adoption of advanced technologies to develop ...

Austin, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Fecal Calprotectin Testing Market Size & Trends: According to SNS Insider, the global Fecal Calprotectin Testing Market was valued at USD 4.51 billion in 2023 ...

SAN DIEGO, Jan. 3, 2018 /PRNewswire/ -- Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is proud to announce the clearance of ...

Patients presenting with persistent abdominal pain and diarrhea are common in clinical practice. Evaluation of these patients, assuming no alarm symptoms, can be difficult. Inflammatory bowel disease ...

The experiences of the 2 NHS trusts who took part in NICE's adoption project have been used to develop practical suggestions for how to implement NICE guidance on faecal calprotectin diagnostic tests ...

(MENAFN- Ameliorate Digital Consultancy) The Calprotectin Testing market is a valuation of US$ 201.1 billion in 2023 and is predicted to reach US$ 363.2 billion by 2029 with registering a CAGR of 6.2% ...

As per Future Market Insights’, the global calprotectin testing market was valued at around US$ 190.6 Mn in 2022, exhibiting growth at a CAGR of 6.2% over the forecast period (2022-2032). Calprotectin ...

The global calprotectin testing industry size is anticipated to secure a valuation of US$ 201.1 billion in 2023 and is projected to reach US$ 360.2 billion by 2033. The market is capturing a CAGR of 6 ...

SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system.

The experiences of the 2 NHS trusts who took part in NICE's adoption project have been used to develop practical suggestions for how to implement NICE guidance on faecal calprotectin diagnostic tests ...